These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 19172464)

  • 1. Molecular expression and functional evidence of a drug efflux pump (BCRP) in human corneal epithelial cells.
    Karla PK; Earla R; Boddu SH; Johnston TP; Pal D; Mitra A
    Curr Eye Res; 2009 Jan; 34(1):1-9. PubMed ID: 19172464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular evidence and functional expression of a novel drug efflux pump (ABCC2) in human corneal epithelium and rabbit cornea and its role in ocular drug efflux.
    Karla PK; Pal D; Quinn T; Mitra AK
    Int J Pharm; 2007 May; 336(1):12-21. PubMed ID: 17156953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and functional activity of breast cancer resistance protein (BCRP, ABCG2) transporter in the human choriocarcinoma cell line BeWo.
    Ceckova M; Libra A; Pavek P; Nachtigal P; Brabec M; Fuchs R; Staud F
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):58-65. PubMed ID: 16445700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of efflux transport of dehydroepiandrosterone sulfate and mitoxantrone at the mouse blood-brain barrier: a minor role of breast cancer resistance protein.
    Lee YJ; Kusuhara H; Jonker JW; Schinkel AH; Sugiyama Y
    J Pharmacol Exp Ther; 2005 Jan; 312(1):44-52. PubMed ID: 15448171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and functional characterization of breast cancer resistance protein in human bronchial epithelial cells (Calu-3).
    Paturi DK; Kwatra D; Ananthula HK; Pal D; Mitra AK
    Int J Pharm; 2010 Jan; 384(1-2):32-8. PubMed ID: 19782742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive overexpression of P-glycoprotein, rather than breast cancer resistance protein or organic cation transporter 1, contributes to acquisition of imatinib-resistance in K562 cells.
    Hirayama C; Watanabe H; Nakashima R; Nanbu T; Hamada A; Kuniyasu A; Nakayama H; Kawaguchi T; Saito H
    Pharm Res; 2008 Apr; 25(4):827-35. PubMed ID: 17934801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C.
    Allen JD; van Loevezijn A; Lakhai JM; van der Valk M; van Tellingen O; Reid G; Schellens JH; Koomen GJ; Schinkel AH
    Mol Cancer Ther; 2002 Apr; 1(6):417-25. PubMed ID: 12477054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs.
    Matsson P; Pedersen JM; Norinder U; Bergström CA; Artursson P
    Pharm Res; 2009 Aug; 26(8):1816-31. PubMed ID: 19421845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P-glycoprotein and breast cancer resistance protein affect disposition of tandutinib, a tyrosine kinase inhibitor.
    Yang JJ; Milton MN; Yu S; Liao M; Liu N; Wu JT; Gan L; Balani SK; Lee FW; Prakash S; Xia CQ
    Drug Metab Lett; 2010 Dec; 4(4):201-12. PubMed ID: 20670210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan.
    Jonker JW; Smit JW; Brinkhuis RF; Maliepaard M; Beijnen JH; Schellens JH; Schinkel AH
    J Natl Cancer Inst; 2000 Oct; 92(20):1651-6. PubMed ID: 11036110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Regulation mechanism of breast cancer resistance protein by toremifene to reverse BCRP-mediated multidrug resistance in breast cancer cells].
    Zhang YH; Li G; Yu J; Xu MS; Liu ZX
    Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):654-60. PubMed ID: 22340044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT).
    Guo A; Marinaro W; Hu P; Sinko PJ
    Drug Metab Dispos; 2002 Apr; 30(4):457-63. PubMed ID: 11901101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The systemic exposure of an N-methyl-D-aspartate receptor antagonist is limited in mice by the P-glycoprotein and breast cancer resistance protein efflux transporters.
    Polli JW; Baughman TM; Humphreys JE; Jordan KH; Mote AL; Webster LO; Barnaby RJ; Vitulli G; Bertolotti L; Read KD; Serabjit-Singh CJ
    Drug Metab Dispos; 2004 Jul; 32(7):722-6. PubMed ID: 15205387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of LW6 as a new potent inhibitor of breast cancer resistance protein.
    Song JG; Lee YS; Park JA; Lee EH; Lim SJ; Yang SJ; Zhao M; Lee K; Han HK
    Cancer Chemother Pharmacol; 2016 Oct; 78(4):735-44. PubMed ID: 27520631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Establishment of BCRP expressed pig kidney cell line LLC-PK1/BCRP and its biological profile].
    Tian Y; Qu BX; Yao Y; Zeng S
    Yao Xue Xue Bao; 2012 Dec; 47(12):1599-604. PubMed ID: 23460964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The "specific" P-glycoprotein inhibitor Tariquidar is also a substrate and an inhibitor for breast cancer resistance protein (BCRP/ABCG2).
    Kannan P; Telu S; Shukla S; Ambudkar SV; Pike VW; Halldin C; Gottesman MM; Innis RB; Hall MD
    ACS Chem Neurosci; 2011 Feb; 2(2):82-9. PubMed ID: 22778859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular evidence and functional expression of multidrug resistance associated protein (MRP) in rabbit corneal epithelial cells.
    Karla PK; Pal D; Mitra AK
    Exp Eye Res; 2007 Jan; 84(1):53-60. PubMed ID: 17083930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2).
    Robey RW; Honjo Y; van de Laar A; Miyake K; Regis JT; Litman T; Bates SE
    Biochim Biophys Acta; 2001 Jun; 1512(2):171-82. PubMed ID: 11406094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperforin inhibits P-gp and BCRP activities in chronic lymphocytic leukaemia cells and myeloid cells.
    Quiney C; Billard C; Faussat AM; Salanoubat C; Kolb JP
    Leuk Lymphoma; 2007 Aug; 48(8):1587-99. PubMed ID: 17701591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of overexpression of efflux proteins on the function and gene expression of endogenous peptide transporters in MDR-transfected MDCKII cell lines.
    Wang Z; Pal D; Patel A; Kwatra D; Mitra AK
    Int J Pharm; 2013 Jan; 441(1-2):40-9. PubMed ID: 23262422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.